PATENT CLAIM ANALYSIS

Application Number: 15865983
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "006100"]

Abstract:
The present disclosure relates to chimeric antisense nucleotides and methods for modulating protein expression levels and/or RNA stability from at least two target mRNAs in a cell simultaneously.

Claim (Index 16):
The method of  claim 11 , wherein the cell is an  Escherichia coli  cell.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11107335', '14371557', '11104705', '13328447', '15317939']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6680858795413167
- 35 USC 102 Novelty (BERT): 0.5327884997952689
- Combined Prediction Score: 0.6545561415667119
- Mean Citation Score: 325.9496460000001
- Max Citation Score: 374.45648
- Similarity Product: 243.80336154680248

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test